Repurposed Medicine in Oncology

Dr. William Makis, a radiologist, oncologist, and cancer researcher with over 100 publications. In this presentation, Dr. Makis explores how existing drugs—originally developed for other medical conditions—are being repurposed to treat cancer and other diseases.

A key focus of the discussion is Fenbendazole, an antiparasitic drug traditionally used in veterinary medicine, which has gained attention for its potential anti-cancer properties. Dr. Makis delves into the mechanisms behind Fenbendazole’s reported effects on cancer cells, including its ability to disrupt microtubules, inhibit glucose uptake, and enhance immune response. He also addresses scientific studies, anecdotal reports, and the broader landscape of repurposed medications in oncology.

This video provides valuable insights into alternative cancer treatment strategies and the ongoing research into drug repurposing as a cost-effective approach to expanding treatment options.